Successful use of rituximab in fibrillary glomerulopathy

Renal Failure

Volumn 36, Issue 7, 2014, Pages 1151-1154

  Chaudhary, Asad ^a   Gyamlani, Geeta ^a,b   Cossey, Nich L ^c   Walker, Patrick D ^c   Wall, Barry M ^a,b  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Nephropathology Associates   (United States)

Author keywords

Chronic kidney disease; Fibrillary; Glomerulonephritis; Rituximab; Treatment

Indexed keywords

IMMUNOLOGIC FACTOR; MONOCLONAL ANTIBODY; RITUXIMAB;

CASE REPORT; GLOMERULONEPHRITIS; GLOMERULUS; HUMAN; MALE; MIDDLE AGED; PATHOLOGY;

ANTIBODIES, MONOCLONAL, MURINE-DERIVED; GLOMERULONEPHRITIS; HUMANS; IMMUNOLOGIC FACTORS; KIDNEY GLOMERULUS; MALE; MIDDLE AGED;

EID: 84904595047     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2014.918832     Document Type: Article

References (14)

1. Ferrario F, Schiaffino E, Boeri R. Fibrillary and immunotactoid glomerulopathies. Ren Fail. 1998;20(6):801-808. (Pubitemid 28541346)
2. Sethi S, Theis JD, Vrana JA, et al. Laser microdissection and proteomic analysis of amyloidosis, cryoglobulinemic GN, fibrillary GN, and immunotactoid glomerulopathy. Clin J Am Soc Nephrol. 2013;8(6):915-921.
3. Fogo A, Qureshi N, Horn RG. Morphologic and clinical features of fibrillary glomerulonephritis versus immunotactoid glomerulopathy. Am J Kidney Dis. 1993;22(3):367-377. (Pubitemid 23263610)
4. Czarnecki PG, Lager DJ, Leung N, Dispenzieri A, Cosio FG, Fervenza FC. Long-term outcome of kidney transplantation in patients with fibrillary glomerulonephritis or monoclonal gammopathy with fibrillary deposits. Kidney Int. 2009;75(4):420-427.
5. Nasr SH, Valeri AM, Cornell LD, et al. Fibrillary glomerulonephritis: a report of 66 cases from a single institution. Clin J Am Soc Nephrol. 2011;6(4):775-784.
6. Collins M, Navaneethan SD, Chung M, et al. Rituximab treatment of fibrillary glomerulonephritis. Am J Kidney Dis. 2008; 52(6):1158-1162.
7. Rosenmann E, Eliakim M. Nephrotic syndrome associated with amyloid-like glomerular deposits. Nephron. 1977;18(5):301-308. (Pubitemid 8087566)
8. Rosenstock JL, Markowitz GS, Valeri AM, Sacchi G, Appel GB, D'Agati VD. Fibrillary and immunotactoid glomerulonephritis: distinct entities with different clinical and pathologic features. Kidney Int. 2003;63(4):1450-1461. (Pubitemid 36350010)
9. Kim HJ, Kang SW, Park SJ, Kim TH, Kang MS, Kim YH. Fibrillary glomerulonephritis associated with Behçet's syndrome. Ren Fail. 2012;34(5):637-639.
10. Coroneos E, Truong L, Olivero J. Fibrillary glomerulonephritis associated with hepatitis C viral infection. Am J Kidney Dis. 1997; 29(1):132-135. (Pubitemid 27020808)
11. Ray S, Rouse K, Appis A, Novak R, Haller NA. Fibrillary glomerulonephritis with hepatitis C viral infection and hypocomplementemia. Ren Fail. 2008;30(7):759-762.
12. Dickenmann M, Schaub S, Nickeleit V, Mihatsch M, Steiger J, Brunner F. Fibrillary glomerulonephritis: early diagnosis associated with steroid responsiveness. Am J Kidney Dis. 2002;40(3):E9(1-5).
13. Boross P, Leusen JH. Mechanisms of action of CD20 antibodies. Am J Cancer Res. 2012;2(6):676-690.
14. Putney JW. TRP, inositol 1,4,5-trisphosphate receptors, and capacitative calcium entry. Proc Natl Acad Sci USA. 1999; 96(26):14669-14671.